Skip to main content
Epigral Limited logo

Epigral Limited — Investor Relations & Filings

Ticker · EPIGRAL ISIN · INE071N01016 LEI · 3358008YTT28JYLL4516 BSE.NS Manufacturing
Open in API
Filings indexed 551 across all filing types
Latest filing 2023-11-06 Earnings Release
Country IN India
Listing BSE.NS EPIGRAL

About Epigral Limited

https://epigral.com/

Epigral Limited, formerly Meghmani Finechem Limited, operates an integrated chemical complex specializing in chlor-alkali and derivative products. The company’s core portfolio includes caustic soda, chlorine, and hydrogen, which serve as building blocks for its value-added downstream products. Key offerings include chloromethanes, hydrogen peroxide, and CPVC resin. Epigral is the first domestic producer of Epichlorohydrin (ECH), utilizing a bio-based manufacturing process. Its products are essential inputs for various applications in pharmaceuticals, textiles, water treatment, and plastics. The company focuses on expanding its specialty chemical portfolio through backward and forward integration, utilizing advanced technology to optimize production efficiency and meet the requirements of diverse global markets.

Recent filings

Filing Released Lang Actions
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the financial results for the quarter ended September 30, 2023 (Q2FY24). It includes key financial metrics such as revenue, PAT, EBITDA, and operational highlights, along with management commentary on performance and strategic updates. The content is typical of an Earnings Release, providing initial quarterly financial results and key highlights without the full detailed financial statements or comprehensive analysis found in an Interim/Quarterly Report (IR). The document length is about 5294 characters, which is consistent with a press release rather than a full quarterly report. Therefore, the appropriate classification is Earnings Release (ER).
2023-11-06 English
Outcome of Board Meeting
Regulatory Filings
2023-11-06 English
Financial Result Updates
Regulatory Filings
2023-11-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges about scheduled investor/analyst meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The document mentions that the latest earnings and corporate presentations are already available on the company's website, but does not contain any financial data or detailed presentations itself. The length is only 1990 characters, which is quite short and consistent with an announcement rather than a full report. There is no indication of financial statements or detailed analysis. Therefore, this document is an announcement of an investor/analyst meeting, which fits best under Regulatory Filings (RNS) as a general regulatory announcement and disclosure under SEBI regulations, rather than a full Investor Presentation (IP) or Earnings Release (ER).
2023-11-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges informing about upcoming investor/analyst meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The document mentions that the latest earnings and corporate presentations are already available on the company's website, but does not contain any financial data or detailed presentations itself. The length is only 1990 characters, indicating it is a brief announcement rather than a full report. Therefore, this document is an announcement of an investor presentation meeting, not the presentation itself. According to the filing definitions and the 'menu vs meal' rule, this fits best under Regulatory Filings (RNS) as a general regulatory announcement about investor meetings and disclosures.
2023-11-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the company's participation in upcoming investor conferences. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content is an announcement of participation in conferences, not a financial report, earnings release, or management discussion. The document length is only 1323 characters, indicating it is a brief announcement rather than a detailed report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2023-11-03 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.